Bcl2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance

Bcl2/Bax Ratios in Chronic Lymphocytic Leukaemia

Commentary

Author Information

Author(s): KE Williamson, JD Kelly, PW Hamilton, D McManus, SR Johnston

Primary Institution: The Queen's University of Belfast

Conclusion

The authors designed an important study, but unfortunately they did not exploit or report all of their data.

Supporting Evidence

  • The authors did not report their findings on the co-expression of Bcl-2 and Bax in B-CLL cells.
  • The study did not report Bcl-2 and Bax protein levels in untreated patient samples after in vitro exposure to chlorambucil.
  • The authors confirmed that Annexin V-positive lymphocytes were apoptotic by morphological assessment, but the criteria used were unclear.

Takeaway

The study looked at proteins related to cell death in cancer, but the authors missed sharing some important results.

Methodology

The authors used flow cytometry to analyze Bcl-2 and Bax protein levels in cancer cells.

Limitations

The study did not report all relevant data, including Bcl-2 and Bax levels in untreated patient samples.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication